BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 56 filers reported holding BIOTA PHARMACEUTIALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $310,000 | -22.9% | 206,912 | -0.2% | 0.00% | – |
Q4 2015 | $402,000 | -2.0% | 207,230 | 0.0% | 0.00% | – |
Q3 2015 | $410,000 | -2.1% | 207,230 | +2.4% | 0.00% | – |
Q2 2015 | $419,000 | +0.2% | 202,364 | +11.5% | 0.00% | – |
Q1 2015 | $418,000 | +8.9% | 181,544 | +6.0% | 0.00% | – |
Q4 2014 | $384,000 | -7.0% | 171,285 | +2.4% | 0.00% | – |
Q3 2014 | $413,000 | -14.7% | 167,307 | -1.5% | 0.00% | – |
Q2 2014 | $484,000 | -53.8% | 169,888 | -0.8% | 0.00% | -100.0% |
Q1 2014 | $1,047,000 | +47.7% | 171,289 | +1.2% | 0.00% | 0.0% |
Q4 2013 | $709,000 | -1.0% | 169,189 | -1.2% | 0.00% | 0.0% |
Q3 2013 | $716,000 | -25.5% | 171,189 | -40.6% | 0.00% | 0.0% |
Q2 2013 | $961,000 | – | 288,352 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 1,617,500 | $3,348,000 | 0.58% |
Broadfin Capital, LLC | 2,611,711 | $5,406,000 | 0.29% |
RA Capital Management | 807,855 | $1,672,000 | 0.17% |
TOWERVIEW LLC | 160,000 | $331,000 | 0.16% |
BVF INC/IL | 350,776 | $726,000 | 0.13% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $606,000 | 0.09% |
Koshinski Asset Management, Inc. | 27,200 | $28,180,000 | 0.02% |
Baker Brothers Advisors | 830,440 | $1,719,000 | 0.02% |
KNOTT DAVID M | 31,833 | $65,894,000 | 0.01% |
SHEPHERD KAPLAN KROCHUK, LLC | 26,756 | $55,000 | 0.01% |